Premier Shockwave, Inc.

Premier Shockwave, Inc., headquartered in Knoxville, Tennessee, manufactures and leases extracorporeal shockwave therapy devices—principally its proprietary OssaTron orthotripsy equipment—and provides consumable supplies and trained technician services to the Department of Defense and Veterans Affairs as a prime contractor across 343 federal awards. The company is a for-profit Subchapter S Corporation competing predominantly in full-and-open, non-set-aside procurements, though it holds one Total Small Business set-aside IDC with the Defense Health Agency. Premier Shockwave operates as a pure prime contractor (100% of awards) with no subcontractor relationships reported across its federal footprint.

The Defense Health Agency dominates Premier Shockwave's customer concentration by dollar value (99 awards, $37.6 million combined potential value), while the Department of the Army Medical Command drives volume (176 awards, $23.9 million), together accounting for 97% of award count and 98% of potential value. The Department of the Navy Bureau of Medicine and Surgery, the Air Force Air Education and Training Command, and Veterans Affairs supplement the base. Place of performance spans military treatment facilities nationwide—Fort Campbell, Fort Gordon, Fort Stewart, Fort Benning, Fort Moore, Fort Eisenhower, Fort Cavazos, Lewis-McChord, Travis Air Force Base, Camp Pendleton, Walter Reed, and VA medical centers across the system—with administrative oversight in Knoxville, Tennessee.

Premier Shockwave holds six significant parent vehicles: a $5 million Total Small Business Indefinite Delivery Contract with DHA (Medical Readiness Contracting Office–West) effective through September 2028; a $2.67 million single-award IDC for shockwave therapy services with DHA (expired May 2025 but generated multiple delivery orders); a $1.8 million BPA with Air Education and Training Command for OssaTron equipment rental through November 2026; a $1.5 million BPA with DHA for OssaTron orthotripsy products through December 2028; a $7 million DHA BPA for surgical supplies and medical instruments (expired September 2025); and a $231.5 thousand BPA with Air Mobility Command for shockwave therapy at Travis AFB (expired December 2024). The largest active vehicles by task order volume are the DHA surgical supplies BPA (25 calls, $860 thousand) and the Army's blanket purchase agreement W91YU013A0009 (21 calls, $1.3 million). Recent work exemplifies the vendor's core capability: a $229.1 thousand Total Small Business delivery order from DHA in April 2026 for podiatry electromedical services at Fort Campbell, a $363.5 thousand purchase order for extracorporeal shockwave treatment services at Fort Meade in March 2026, and a $1.73 million definitive contract with VA Veterans Integrated Service Network 7 awarded in August 2021 (extending through August 2025) for OssaTron devices, consumables, and technician services at VA medical facilities in Augusta, Georgia.

Activity volume contracted sharply: 27 awards in 2022, dropping to 14 in 2023 and 7 each in 2024 and 2025, with only 4 awards recorded in 2026. Only 3 awards (combined potential value $640 thousand) reach ultimate completion inside the next twenty-four months, limiting near-term recompete exposure. Service Contract Inventory reporting captures minimal activity—only $163 thousand across three prime records spanning FY2023–FY2024, representing approximately 0.1–0.2 FTEs and reflecting Premier Shockwave's business model centered on equipment lease and sale rather than labor-hour service delivery. On SCI-reportable prime contracts, government-paid rates cluster tightly around $300/hr (10th percentile $296, median $300, 90th percentile $304), suggesting standardized pricing across small delivery teams where captured. No subcontractor hours were reported across SCI-reportable work.

Premier Shockwave's federal profile is narrowly specialized: the vendor manufactures and leases orthotripsy devices and supports military orthopedic and podiatry clinics across the defense and Veterans Affairs healthcare systems. The company competes in full-and-open procurement against commercial medical-device suppliers and does not operate as a feeder subcontractor to larger primes. Recompete risk is modest in the next twenty-four months, but the steep decline in award count since 2022 signals either market saturation, contract consolidation within existing IDVs, or competitive displacement in the shockwave therapy segment.